Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 8/20/2017 3:14:42 PM - Followers: 710 - Board type: Free - Posts Today: 55

Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.

Patent Info:

Clinical Trials:
Recent News:
Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Statement of Changes in Beneficial Ownership (4) 08/18/2017 04:55:37 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 08/14/2017 05:15:55 PM
AVXL News: Securities Registration: Employee Benefit Plan (s-8) 08/11/2017 05:22:15 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 08/11/2017 04:42:04 PM
AVXL News: Quarterly Report (10-q) 08/07/2017 04:41:07 PM
#109577  Sticky Note Requested Dosing Extension falconer66a 06/24/17 10:45:47 PM
#108606  Sticky Note Lots of negativity on the board today. sliceanddice59 06/15/17 01:27:12 AM
#103034  Sticky Note To answer your good questions. falconer66a 04/26/17 10:18:09 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#116327   Would you disagree with any of the following F1ash 08/20/17 03:14:42 PM
#116326   It’s a Weigh the Risks Decision falconer66a 08/20/17 03:13:27 PM
#116325   Afternoon traderpete, and I'll admit that I'm not polarbear77 08/20/17 02:46:01 PM
#116323   OFP while you're answering a few questions this polarbear77 08/20/17 02:01:34 PM
#116320   But What Could Aricept Users Know falconer66a 08/20/17 01:06:33 PM
#116319   True, Rett could prove an equally hot potato Investor2014 08/20/17 12:19:25 PM
#116318   Modulating Sig-1 is analogous to speaking a foreign basparks79 08/20/17 12:03:57 PM
#116317   Thanks for your response and agree---just checking for plexrec 08/20/17 11:20:35 AM
#116316   I agree with you. DMD is a sliceanddice59 08/20/17 11:15:34 AM
#116315   The secret sauce was the DMD parents advocacy Investor2014 08/20/17 11:09:13 AM
#116314   Disclaimer: I don't profess to be any sort F1ash 08/20/17 11:08:09 AM
#116313   Several SAB members also serve on multiple other Investor2014 08/20/17 11:06:56 AM
#116312   I do not mind the exposure that certain LakeshoreLeo1953 08/20/17 11:00:10 AM
#116309   Eteplirsen was approved last year by the FDA sliceanddice59 08/20/17 10:31:36 AM
#116307   Share Structure LGL8054 08/20/17 10:04:13 AM
#116305   How significant is the SAB to Anavex?? plexrec 08/20/17 10:02:24 AM
#116304   And in the face of all that you ohsaycanyousee82 08/20/17 09:53:36 AM
#116299   OFP, keep it up. Your opinion is as kld2 08/20/17 09:25:06 AM
#116298   Not my math Xena. It does have SOME LakeshoreLeo1953 08/20/17 09:22:59 AM
#116293   Makes you wonder why all the brilliant minds ohsaycanyousee82 08/20/17 08:29:33 AM
#116292   No, a link to the trials you are XenaLives 08/20/17 08:26:28 AM
#116291   Got a link those alleged trials There OFP 08/20/17 08:21:50 AM
#116290   Fact Remains, Aricept Is Weak, Inadequate Alzheimer's Treatment OFP 08/20/17 08:17:04 AM
#116289   Good point. I was just thinking Alzhiemer's. baltimorebullet 08/20/17 08:09:38 AM
#116288   Donepezil sucks - a true "nobrainer"... Thanks. XenaLives 08/20/17 07:45:46 AM
#116287   Good article. We may see this hurdle for Rett Amatuer17 08/20/17 07:25:50 AM
#116286   Let's see what 'real world' people think of Donepezil.. nobrainerstocks 08/20/17 07:13:12 AM
#116284   While this shouldn't be a problem for us baltimorebullet 08/20/17 06:37:11 AM
#116281   Well said Jimmy. Or. A2-73 is the Agonist that McMagyar 08/20/17 06:13:36 AM
#116280   There may be minimal risk in buying and Investor2014 08/20/17 05:48:45 AM
#116277   That's a pretty vivid dream; thanks for taking basparks79 08/20/17 02:04:47 AM
#116276   Anavex is screaming EPILEPSY as an indication by jimmy667 08/20/17 01:07:55 AM
#116273   Donepezil is an S1 agonist with a higher jimmy667 08/20/17 12:34:05 AM
#116272   Thanks Rocalinda for your "fair and balanced" approach tredenwater2 08/19/17 11:54:28 PM
#116270   Just imagine if Gotleib met with Anavex's SAB attilathehunt 08/19/17 11:32:11 PM
#116269   The onus is on you when you claim XenaLives 08/19/17 11:16:14 PM
#116268   Got a link those alleged trials - who XenaLives 08/19/17 11:14:42 PM
#116265   Fact Remains, Aricept Is Weak, Inadequate Alzheimer's Treatment falconer66a 08/19/17 10:54:29 PM
#116264   If you haven't seen it, PBS's documentary about A_Good_Day_2 08/19/17 10:52:48 PM
#116262   Donepezil is an S1 agonist with a higher frrol 08/19/17 10:20:51 PM
#116261   Anavex assists endoplasmic ptm Bearly Bullish 08/19/17 10:17:27 PM
#116259   Anavex 2-73 is a pcp analogue Bearly Bullish 08/19/17 09:58:50 PM
#116258   Ok, Then; A Retail Shareholders Advisory Board falconer66a 08/19/17 09:51:38 PM
#116257   Those are typically reserved for large institutional or rocalinda 08/19/17 09:35:50 PM
#116256   Perhaps There Should Be A Shareholders Advisory Board falconer66a 08/19/17 09:28:42 PM
#116255   I would second that motion. rocalinda 08/19/17 09:21:21 PM
#116254   ..not to mention the beautiful Nell Rebowe, who rocalinda 08/19/17 09:19:28 PM
#116253   I'm Waiting To Be Invited Onto the Advisors Board. falconer66a 08/19/17 09:14:42 PM
#116252   Should also note that Daniel Klamer has his neiu 08/19/17 09:12:00 PM
#116248   Way to go Rocalinda. Our SAB is like poonch1ne 08/19/17 09:04:33 PM